Health Canada Approves Roflumilast Cream 0.15% (Zoryve, Arcutis) for AD
Health Canada has approved roflumilast cream 0.15% (Zoryve, Arcutis) for the treatment of mild-to-moderate atopic dermatitis (AD) in adults and children aged 6 and up.
Day: March 17, 2025